Liu X - Search Results

1

Efficacy and safety of inetetamab-containing regimens in patients with HER2-positive metastatic breast cancer: a real-world retrospective study in China.

Liu X, Zhang P, Li C, Song X, Liu Z, Shao W, Li S, Wang X, Yu Z. Liu X, et al. Among authors: liu z. Front Oncol. 2023 Jun 19;13:1136380. doi: 10.3389/fonc.2023.1136380. eCollection 2023. Front Oncol. 2023. PMID: 37404769 Free PMC article.

2

PR status is a more decisive factor in efficacy of adding pertuzumab into neoadjuvant therapy for HER2-positive and lymph node-positive breast cancer than ER status: a real-world retrospective study in China.

Liu X, Liu Z, Li C, Song X, Wang X, Li S, Yu Z. Liu X, et al. Among authors: liu z. World J Surg Oncol. 2023 Sep 18;21(1):296. doi: 10.1186/s12957-023-03178-4. World J Surg Oncol. 2023. PMID: 37723497 Free PMC article.

3

Predictive factors and prognosis of immune checkpoint inhibitor-related pneumonitis in non-small cell lung cancer patients.

Liu X, Hao N, Yang S, Li J, Wang L. Liu X, et al. Front Oncol. 2023 Apr 26;13:1145143. doi: 10.3389/fonc.2023.1145143. eCollection 2023. Front Oncol. 2023. PMID: 37182127 Free PMC article.

4

Intratumoral microbiota of pancreatic ductal adenocarcinoma impact patient prognosis by influencing tumor microenvironment.

Leng J, Xu H, Liu X, Yang Y, Ning C, Sun L, Qu J, Ke X, Lan X. Leng J, et al. Among authors: liu x. Discov Oncol. 2024 Sep 13;15(1):443. doi: 10.1007/s12672-024-01320-6. Discov Oncol. 2024. PMID: 39271584 Free PMC article.

5

A Phase II Clinical Study on Apatinib Plus Vinorelbine in Refractory HER2-Negative Breast Cancer and its Metabolic Implications of Drug Resistance.

Wu J, Deng P, Zou L, Liu X, Tang X, Zeng X, Liu S. Wu J, et al. Among authors: liu x, liu s. Curr Cancer Drug Targets. 2024 Oct 1. doi: 10.2174/0115680096303785240822155217. Online ahead of print. Curr Cancer Drug Targets. 2024. PMID: 39354768 Clinical Trial.

6

Combined systemic immune-inflammatory index and prognostic nutritional index predicts the efficacy and prognosis of ES-SCLC patients receiving PD-L1 inhibitors combined with first-line chemotherapy.

Ge Y, Liu X, Xu Y, Su Y, Li Y, Wang L. Ge Y, et al. Among authors: liu x. Front Oncol. 2024 Dec 4;14:1485849. doi: 10.3389/fonc.2024.1485849. eCollection 2024. Front Oncol. 2024. PMID: 39697233 Free PMC article.

7

The effect of carbon nanoparticles staining on lymph node tracking in colorectal cancer: A propensity score matching analysis.

Liu F, Peng D, Liu XY, Liu XR, Li ZW, Wei ZQ, Wang CY. Liu F, et al. Front Surg. 2023 Mar 1;10:1113659. doi: 10.3389/fsurg.2023.1113659. eCollection 2023. Front Surg. 2023. PMID: 36936663 Free PMC article.

8

Anti-neuroinflammatory effect of hydroxytyrosol: a potential strategy for anti-depressant development.

Li S, Shao H, Sun T, Guo X, Zhang X, Zeng Q, Fang S, Liu X, Wang F, Liu F, Ling P. Li S, et al. Among authors: liu x, liu f. Front Pharmacol. 2024 Mar 1;15:1366683. doi: 10.3389/fphar.2024.1366683. eCollection 2024. Front Pharmacol. 2024. PMID: 38495098 Free PMC article.

9

The Effect of Bilirubin on Clinical Outcomes of Patients With Colorectal Cancer Surgery: A Ten-Year Volume Single-Center Retrospective Study.

Li ZW, Zhang B, Liu XY, Kang B, Liu XR, Yuan C, Wei ZQ, Peng D. Li ZW, et al. Nutr Cancer. 2023;75(5):1315-1322. doi: 10.1080/01635581.2023.2170430. Epub 2023 May 2. Nutr Cancer. 2023. PMID: 37130828

10

Phase angle is a predictor for postoperative complications in colorectal cancer.

Liu XY, Kang B, Lv Q, Wang ZW. Liu XY, et al. Front Nutr. 2024 Aug 16;11:1446660. doi: 10.3389/fnut.2024.1446660. eCollection 2024. Front Nutr. 2024. PMID: 39221167 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

137,522 results

Search Page

Filters